Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshihiro Shibata

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Cancer Immunology, Immunotherapy : CII|August 7, 2023
Preferential B cell differentiation by combined immune checkpoint blockade for renal cell carcinoma is associated with clinical response and autoimmune reactionsKoki Uehara, Kenro Tanoue, Kyoko Yamaguchi, et al.
Medicine|June 21, 2018
A phase 2 study of fosaprepitant combined with high-dose dexamethasone for Japanese cancer patients receiving highly emetogenic chemotherapyHozumi Kumagai, Hitoshi Kusaba, Takeharu Yamanaka, et al.
Anticancer Research|May 7, 2017
Efficacy and Safety Analysis of Oxaliplatin-based Chemotherapy for Advanced Gastric CancerKyoko Inadomi, Hitoshi Kusaba, Yuzo Matsushita, et al.
Journal of Applied Clinical Medical Physics|July 2, 2024
Dosimetric impact of the respiratory motion of the liver dome in stereotactic body radiotherapy for spine metastasis: A planning studyHiroyuki Okamoto, Midori Nonaka, Takahito Chiba, et al.
Journal of Medicinal Chemistry|June 10, 2008
A novel class of cycloalkano[b]pyridines as potent and orally active opioid receptor-like 1 antagonists with minimal binding affinity to the hERG K+ channelTakashi Yoshizumi, Hirobumi Takahashi, Hiroshi Miyazoe, et al.
Anti-Cancer Drugs|January 16, 2016
Efficacy and safety analysis of chemotherapy for advanced colitis-associated colorectal cancer in JapanKenta Nio, Daijiro Higashi, Hozumi Kumagai, et al.
Nature Communications|October 19, 2024
Spatial dynamics of CD39<sup>+</sup>CD8<sup>+</sup> exhausted T cell reveal tertiary lymphoid structures-mediated response to PD-1 blockade in esophageal cancerKenro Tanoue, Hirofumi Ohmura, Koki Uehara, et al.
Internal Medicine (Tokyo, Japan)|February 5, 2014
Effects of recombinant human soluble thrombomodulin treatment for disseminated intravascular coagulation at a single institution--an analysis of 62 cases caused by infectious diseases and 30 cases caused by hematological diseasesNoriaki Kawano, Akira Tasaki, Takuro Kuriyama, et al.
Journal of Medicinal Chemistry|March 11, 2024
Fragment-Based Discovery of Allosteric Inhibitors of SH2 Domain-Containing Protein Tyrosine Phosphatase-2 (SHP2)James E H Day, Valerio Berdini, Joan Castro, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Cancer Immunology, Immunotherapy : CII|August 7, 2023
Preferential B cell differentiation by combined immune checkpoint blockade for renal cell carcinoma is associated with clinical response and autoimmune reactionsKoki Uehara, Kenro Tanoue, Kyoko Yamaguchi, et al.
Medicine|June 21, 2018
A phase 2 study of fosaprepitant combined with high-dose dexamethasone for Japanese cancer patients receiving highly emetogenic chemotherapyHozumi Kumagai, Hitoshi Kusaba, Takeharu Yamanaka, et al.
Anticancer Research|May 7, 2017
Efficacy and Safety Analysis of Oxaliplatin-based Chemotherapy for Advanced Gastric CancerKyoko Inadomi, Hitoshi Kusaba, Yuzo Matsushita, et al.
Journal of Applied Clinical Medical Physics|July 2, 2024
Dosimetric impact of the respiratory motion of the liver dome in stereotactic body radiotherapy for spine metastasis: A planning studyHiroyuki Okamoto, Midori Nonaka, Takahito Chiba, et al.
Journal of Medicinal Chemistry|June 10, 2008
A novel class of cycloalkano[b]pyridines as potent and orally active opioid receptor-like 1 antagonists with minimal binding affinity to the hERG K+ channelTakashi Yoshizumi, Hirobumi Takahashi, Hiroshi Miyazoe, et al.
Anti-Cancer Drugs|January 16, 2016
Efficacy and safety analysis of chemotherapy for advanced colitis-associated colorectal cancer in JapanKenta Nio, Daijiro Higashi, Hozumi Kumagai, et al.
Nature Communications|October 19, 2024
Spatial dynamics of CD39<sup>+</sup>CD8<sup>+</sup> exhausted T cell reveal tertiary lymphoid structures-mediated response to PD-1 blockade in esophageal cancerKenro Tanoue, Hirofumi Ohmura, Koki Uehara, et al.
Internal Medicine (Tokyo, Japan)|February 5, 2014
Effects of recombinant human soluble thrombomodulin treatment for disseminated intravascular coagulation at a single institution--an analysis of 62 cases caused by infectious diseases and 30 cases caused by hematological diseasesNoriaki Kawano, Akira Tasaki, Takuro Kuriyama, et al.
Journal of Medicinal Chemistry|March 11, 2024
Fragment-Based Discovery of Allosteric Inhibitors of SH2 Domain-Containing Protein Tyrosine Phosphatase-2 (SHP2)James E H Day, Valerio Berdini, Joan Castro, et al.
Pageof 6